Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Ombrabulin> ?p ?o. }
Showing items 1 to 36 of
36
with 100 items per page.
- Ombrabulin abstract "Ombrabulin is an experimental drug candidate discovered by Ajinomoto and under development by Sanofi-Aventis. It is currently in Phase III clinical trials for the treatment of advanced-stage soft-tissue sarcoma.Ombrabulin was granted orphan drug status by the European Medicines Agency in April 2011.Ombrabulin is a combretastatin A-4 derivative that exerts its antitumor effect by disrupting the formation of blood vessels needed for tumor growth.".
- Ombrabulin iupacName "(2S)-2-Amino-3-hydroxy-N-[2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide".
- Ombrabulin thumbnail Ombrabulin.svg?width=300.
- Ombrabulin wikiPageID "32767728".
- Ombrabulin wikiPageRevisionID "546203801".
- Ombrabulin hasPhotoCollection Ombrabulin.
- Ombrabulin imagefile "Ombrabulin.svg".
- Ombrabulin imagesize "200".
- Ombrabulin iupacname "-2".
- Ombrabulin othernames "AVE-8062; AVE-8062A; AC7700; CS-39-L-Ser.HCl".
- Ombrabulin verifiedrevid "445300917".
- Ombrabulin subject Category:Amino_acid_derivatives.
- Ombrabulin subject Category:Experimental_cancer_drugs.
- Ombrabulin type Abstraction100002137.
- Ombrabulin type AminoAcidDerivatives.
- Ombrabulin type Calculation105802185.
- Ombrabulin type Cognition100023271.
- Ombrabulin type DerivedFunction106014730.
- Ombrabulin type HigherCognitiveProcess105770664.
- Ombrabulin type ProblemSolving105796750.
- Ombrabulin type Process105701363.
- Ombrabulin type PsychologicalFeature100023100.
- Ombrabulin type Thinking105770926.
- Ombrabulin type ChemicalCompound.
- Ombrabulin type ChemicalSubstance.
- Ombrabulin type ChemicalObject.
- Ombrabulin type Thing.
- Ombrabulin comment "Ombrabulin is an experimental drug candidate discovered by Ajinomoto and under development by Sanofi-Aventis. It is currently in Phase III clinical trials for the treatment of advanced-stage soft-tissue sarcoma.Ombrabulin was granted orphan drug status by the European Medicines Agency in April 2011.Ombrabulin is a combretastatin A-4 derivative that exerts its antitumor effect by disrupting the formation of blood vessels needed for tumor growth.".
- Ombrabulin label "Ombrabulin".
- Ombrabulin sameAs m.0h3q5b0.
- Ombrabulin sameAs Q7089934.
- Ombrabulin sameAs Q7089934.
- Ombrabulin sameAs Ombrabulin.
- Ombrabulin wasDerivedFrom Ombrabulin?oldid=546203801.
- Ombrabulin depiction Ombrabulin.svg.
- Ombrabulin isPrimaryTopicOf Ombrabulin.
